S&P Futures

6,995.00 (+0.17%)

Dow Futures

50,280.00 (+0.12%)

Nasdaq Futures

25,392.00 (+0.15%)

Russell 2000 Futures

2,703.60 (+0.28%)

Crude Oil

64.59 (+0.36%)

Gold

5,071.90 (-0.15%)

Silver

82.18 (-0.07%)

EUR/USD

1.1923 (+0.02%)

10-Yr Bond

4.1980 (-0.19%)

VIX

17.31 (-0.29%)

GBP/USD

1.3674 (-0.13%)

USD/JPY

155.2940 (-0.34%)

Bitcoin USD

69,327.78 (-0.58%)

XRP USD

1.43 (+1.89%)

FTSE 100

10,353.29 (-0.32%)

Nikkei 225

57,650.54 (+2.28%)

Clean Energy

Companies that produce or refine oil and gas, oilfield-services and equipment companies, and pipeline operators. This sector also includes companies that mine thermal coal and uranium. Companies in this sector include BP, ExxonMobil, Royal Dutch Shell, and China Shenhua Energy.

Market Cap

2.879T

Market Weight

4.46%

Industries

Companies

253

Industries in This Sector

Industry	Market Weight	YTD Return
All Industries	100.00%	-0.05%
Oil & Gas Integrated	36.72%	2.22%
Oil & Gas Midstream	27.03%	2.66%
Oil & Gas E&P	21.66%	-5.33%
Oil & Gas Equipment & Services	6.93%	-0.82%
Oil & Gas Refining & Marketing	5.74%	2.39%
Uranium	0.95%	-19.51%
Oil & Gas Drilling	0.60%	-19.28%
Thermal Coal	0.36%	-8.00%

More about the largest companies in the sector

Name	Last Price	1 Year Est.	Market Weight	Market Cap	Day Changes %	YTD Return
XOM	109.02	129.33	20.89%	479.153B	+1.30%	+1.35%
CVX	156.34	176.76	12.15%	278.742B	+2.22%	+7.94%
COP	90.63	129.52	5.11%	117.235B	+2.29%	-8.61%
EPD	33.46	36.56	3.16%	72.527B	+2.17%	+6.70%
EOG	125.26	144.81	3.07%	70.452B	+2.51%	+2.19%
WMB	54.38	58.78	2.89%	66.29B	-0.42%	+0.48%
ET	17.46	22.73	2.61%	59.782B	-1.36%	-10.87%
SLB	41.37	53.04	2.55%	58.421B	+4.05%	+7.90%
KMI	26.14	29.90	2.53%	58.074B	-0.65%	-4.60%
MPLX	52.70	55.44	2.34%	53.691B	+0.73%	+10.11%

ETF Opportunities

Name	Last Price	Net Assets	Expense Ratio	YTD Return
XLE	87.43	32.985B	0.08%	+2.07%
AMLP	50.33	10.735B	0.85%	+4.51%
VDE	121.24	9.613B	0.09%	-0.06%
MLPX	60.00	2.844B	0.45%	-0.92%
XOP	122.56	2.109B	0.35%	-7.41%

Mutual Fund Opportunities

View all

Name	Last Price	Net Assets	Expense Ratio	YTD Return
VENAX	60.55	9.613B	0.09%	+0.07%
VGELX	83.14	5.669B	0.36%	+2.83%
VGENX	44.31	5.669B	0.36%	+2.81%
SPNNX	5.99	4.167B	6.24%	+2.92%
SPMQX	6.23	4.167B	6.24%	+3.15%

Stocks

Symbol	Price	Change	%Change
DXST	4.9500	3.3500	209.3750%
LASE	2.4200	1.4925	160.9164%
LILPV	28.5000	15.5000	119.2308%
BJDX	4.3400	2.1700	100.0000%
STAK	1.9000	0.9250	94.8718%

Symbol	Price	Change	%Change
HKIT	0.6200	-5.9600	-90.5775%
JZ	0.7000	-2.4000	-77.4194%
MYPSW	0.0016	-0.0034	-68.0000%
GIPRW	0.0251	0.0000	0.0000%
OPFI	8.3600	-0.0200	-0.2387%

Symbol	Price	Change	%Change
PMI	0.2700	0.1016	60.3325%
HUBC	0.4800	-0.0350	-6.7961%
SOXS	5.1700	-1.0900	-17.4121%
GPUS	0.2300	0.0532	30.0905%
LASE	2.4200	1.4925	160.9164%

Clean Energy News

Warren Buffett's Successor, Greg Abel, Has More Than 28% of Berkshire Hathaway's $330 Billion Portfolio Invested in 2 AI Titans

In his first quarter as Berkshire Hathaway's CEO, Abel has made it clear that tech stocks are firmly on the menu in the post-Buffett era.

Buy 2 Vanguard Index Funds to Beat the S&P 500 in the Next Year, According to Wall Street

Wall Street analysts expect market-beating returns from healthcare and communication services stocks over the next year.

Why Arm Stock Skyrocketed 68% in May

Arm stock's year-to-date return in 2026 is a jaw-dropping 268% as of June 2.

Zhihu Inc. Announces Change of Non-Executive Director

BEIJING, June 03, 2026 ( GLOBE NEWSWIRE ) -- Zhihu Inc. ( "Zhihu" or the "Company" ) ( NYSE: ZH. HKEX: 2390 ) , a leading online content community in China, today announced the appointment of Mr. Qu Chen as a non-executive director of the Company.

Zhihu Inc. Reports Unaudited First Quarter 2026 Financial Results

BEIJING, China, June 03, 2026 ( GLOBE NEWSWIRE ) -- Zhihu Inc. ( "Zhihu" or the "Company" ) ( NYSE: ZH.

Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation

• Expands availability of Nociscan in the greater Los Angeles area with leading neuroscience group • Adds to growing body of real-world evidence with study comparing chemical biomarker data from Nociscan with bone metabolic information from SPECT-CT • Supports scalable growth strategy while ...

Is Meta's AI Spending Spree Reckless or Genius?

The metaverse comparisons are missing the big picture.